Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| oligodendrocyte precursor cell | 15 studies | 84% ± 17% | |
| astrocyte | 12 studies | 46% ± 19% | |
| GABAergic neuron | 11 studies | 68% ± 22% | |
| glutamatergic neuron | 11 studies | 84% ± 14% | |
| oligodendrocyte | 11 studies | 38% ± 19% | |
| microglial cell | 9 studies | 38% ± 16% | |
| neuron | 6 studies | 40% ± 16% | |
| endothelial cell | 6 studies | 47% ± 18% | |
| retinal bipolar neuron | 4 studies | 47% ± 33% | |
| interneuron | 4 studies | 79% ± 18% | |
| differentiation-committed oligodendrocyte precursor | 3 studies | 63% ± 11% | |
| GABAergic interneuron | 3 studies | 79% ± 1% | |
| GABAergic amacrine cell | 3 studies | 38% ± 11% | |
| glycinergic amacrine cell | 3 studies | 32% ± 11% | |
| retinal ganglion cell | 3 studies | 26% ± 8% | |
| rod bipolar cell | 3 studies | 78% ± 29% | |
| amacrine cell | 3 studies | 42% ± 24% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 95% | 464.65 | 2521 / 2642 | 90% | 11.26 | 632 / 705 |
| prostate | 44% | 38.28 | 107 / 245 | 14% | 0.49 | 71 / 502 |
| adrenal gland | 6% | 4.89 | 16 / 258 | 42% | 6.70 | 97 / 230 |
| lung | 38% | 41.21 | 221 / 578 | 6% | 0.21 | 70 / 1155 |
| intestine | 39% | 44.76 | 376 / 966 | 1% | 0.03 | 5 / 527 |
| bladder | 33% | 31.24 | 7 / 21 | 3% | 0.06 | 15 / 504 |
| muscle | 34% | 25.35 | 273 / 803 | 0% | 0 | 0 / 0 |
| skin | 0% | 0.38 | 9 / 1809 | 31% | 4.21 | 145 / 472 |
| esophagus | 23% | 20.87 | 336 / 1445 | 3% | 0.08 | 6 / 183 |
| liver | 14% | 9.75 | 31 / 226 | 9% | 0.20 | 35 / 406 |
| ovary | 2% | 1.25 | 3 / 180 | 19% | 0.45 | 82 / 430 |
| uterus | 14% | 9.12 | 23 / 170 | 6% | 0.14 | 28 / 459 |
| stomach | 17% | 14.01 | 62 / 359 | 1% | 0.01 | 3 / 286 |
| kidney | 3% | 4.39 | 3 / 89 | 10% | 0.64 | 91 / 901 |
| adipose | 10% | 11.38 | 125 / 1204 | 0% | 0 | 0 / 0 |
| heart | 10% | 6.27 | 83 / 861 | 0% | 0 | 0 / 0 |
| pancreas | 2% | 1.30 | 7 / 328 | 7% | 0.20 | 13 / 178 |
| blood vessel | 8% | 7.65 | 111 / 1335 | 0% | 0 | 0 / 0 |
| thymus | 0% | 0.23 | 3 / 653 | 5% | 0.10 | 28 / 605 |
| breast | 2% | 1.32 | 10 / 459 | 1% | 0.02 | 11 / 1118 |
| eye | 0% | 0 | 0 / 0 | 1% | 0.04 | 1 / 80 |
| spleen | 1% | 0.42 | 2 / 241 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 0.04 | 1 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0045211 | Cellular component | postsynaptic membrane |
| GO_0031012 | Cellular component | extracellular matrix |
| GO_0005615 | Cellular component | extracellular space |
| Gene name | LRRTM4 |
| Protein name | Leucine rich repeat transmembrane neuronal 4 LRRTM4 protein (Leucine rich repeat transmembrane neuronal 4) LRRTM4 protein (cDNA FLJ12568 fis, clone NT2RM4000857, weakly similar to LEUCINE-RICH ALPHA-2-GLYCOPROTEIN) Leucine-rich repeat transmembrane neuronal protein 4 |
| Synonyms | UNQ3075/PRO9907 |
| Description | FUNCTION: May play a role in the development and maintenance of the vertebrate nervous system. Exhibits strong synaptogenic activity, restricted to excitatory presynaptic differentiation (By similarity). . |
| Accessions | ENST00000456154.1 Q9H9T0 Q86VH4 C9JM64 ENST00000409911.5 Q4KMX1 ENST00000409884.6 [Q86VH4-1] ENST00000409282.1 ENST00000409088.3 [Q86VH4-2] B8ZZ84 ENST00000409093.1 [Q86VH4-1] |